| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | SVP&Pres, Lillydiab &Lillyusa | Sr. VP &Pres., Lilly Diabetes
2 companies
Conterno Enrique A is a Chief Executive Officer at KYNB with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $148.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2015 | LLY Eli Lilly & Co | Sr. VP &Pres., Lilly Diabetes | Sell | 25,000 | $83.88 | $2,097,000.00 | -22.1% |